KAREN JOHNSON: Open Payments
NPI 1730321241 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 80 payments from 20 companies in 2025. Trend: 2023 $1,387 · 2024 $1,778 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 25 | $237 |
| AstraZeneca Pharmaceuticals LP | 11 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $186 |
| Lilly USA, LLC | 9 | $181 |
| Merck Sharp & Dohme LLC | 5 | $87 |
| Exact Sciences Corporation | 3 | $74 |
| PFIZER INC. | 4 | $62 |
| Viatris Specialty LLC | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: Kerendia, JARDIANCE, EVENITY, OTEZLA, FARXIGA, MOUNJARO, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across MD — which companies pay providers there.
